Adverse Events and Patient Tolerability of Apomorphine SL 2 and 3 mg: A Cross-Study Analysis of Phase II and III Studies

By Ralph D.J.   Sleep D.J.   Perdok R.J.   Padley R.J.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 21-27

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction

By Dula E.   Keating W.   Siami P.F.   Edmonds A.   O'neil J.   Buttler S.  

Urology, Vol. 56, Iss. 1, 2000-07 ,pp. : 130-135

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

By Roehrborn C.G.   Siegel R.L.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 406-415

Elsevier

Access to resources Recommend Favorite

Intravesical Capsaicin in Patients with Detrusor Hyper-reflexia: A Placebo-controlled Cross-over Study

By Petersen T.   Nielsen J. B.   Schrøder H. D.  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 2, 1999-08 ,pp. : 104-110

Informa Healthcare

Access to resources Recommend Favorite

Brain Activation Patterns during Video Sexual Stimulation Following the Administration of Apomorphine: Results of a Placebo-Controlled Study

By Montorsi F.   Perani D.   Anchisi D.   Salonia A.   Scifo P.   Rigiroli P.   Deho F.   De Vito M.L.   Heaton J.   Rigatti P.   Fazio F.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 405-411

Elsevier

Access to resources Recommend Favorite